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Endogenous reference RNAs for 
microRNA quantitation in formalin-
fixed, paraffin-embedded lymph 
node tissue
Katsushige Inada  1, Yasushi Okoshi1,2, Yukiko Cho-Isoda3, Shingo Ishiguro3, Hisashi Suzuki2,4, 
Akinori Oki2,5, Yoshio Tamaki2,6, Toru Shimazui2,7, Hitoaki Saito8, Mitsuo Hori1, Tatsuo Iijima8 & 
Hiroshi Kojima2,3
Lymph node metastasis is one of the most important factors for tumor dissemination. Quantifying 
microRNA (miRNA) expression using real-time PCR in formalin-fixed, paraffin-embedded (FFPE) 
lymph node can provide valuable information regarding the biological research for cancer metastasis. 
However, a universal endogenous reference gene has not been identified in FFPE lymph node. This 
study aimed to identify suitable endogenous reference genes for miRNA expression analysis in 
FFPE lymph node. FFPE lymph nodes were obtained from 41 metastatic cancer and from 16 non-
cancerous tissues. We selected 10 miRNAs as endogenous reference gene candidates using the global 
mean method. The stability of candidate genes was assessed by the following four statistical tools: 
BestKeeper, geNorm, NormFinder, and the comparative ΔCt method. miR-103a was the most stable 
gene among candidate genes. However, the use of a single miR-103a was not recommended because 
its stability value exceeded the reference value. Thus, we combined stable genes and investigated the 
stability and the effect of gene normalization. The combination of miR-24, miR-103a, and let-7a was 
identified as one of the most stable sets of endogenous reference genes for normalization in FFPE 
lymph node. This study may provide a basis for miRNA expression analysis in FFPE lymph node tissue.
Formalin fixation and paraffin embedding is the universal standard pathological technique for preserving tissue. 
These formalin-fixed, paraffin-embedded (FFPE) tissue samples are the most readily available, archival mate-
rial for discovering biomarkers and validating human diseases; however, formalin fixation and paraffin embed-
ding induces extensive degradation of nucleic acids such as DNA or mRNA1,2. MicroRNAs (miRNAs), a class of 
non-coding small RNAs (approximately 22 nucleotides), are relatively well preserved in FFPE tissue. Previous 
studies have revealed a positive correlation in miRNAs expression between FFPE tissues and frozen cells/tis-
sues3–5. miRNAs regulate post-transcriptional gene expression by binding to the complementary sites of target 
mRNAs and have important functions in oncogenesis or as tumor suppressor due to their prominent role in 
cancer pathway regulation6. Because of their stability in FFPE tissue, miRNAs can serve as invaluable cancer 
biomarkers.
Quantitative real-time PCR (qRT-PCR) using the threshold cycle (Ct) value is one of the most sensitive meth-
ods for miRNA detection and quantification. In this method, an endogenous reference gene, which is stably 
expressed in every sample, regardless of the pathogenesis or diagnosis, is used for normalization. Careful vali-
dation of the endogenous reference gene is crucial for obtaining accurate data regarding miRNA expression7. To 
the best of our knowledge, a universal reference gene that is suitable for all FFPE tissues has not been found. For 
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this reason, appropriate reference miRNAs should be selected for specific experiments, target cells, or tissues of 
interest. A stable endogenous reference gene should have high and constant level of expression in all FFPE tissue 
samples.
In this study, we investigated candidate miRNA reference genes in lymph nodes. Lymph node biopsy is gener-
ally performed to diagnose lymph node swelling, particularly when malignancy is suspected, and this procedure 
is also employed to determine the tissue type of metastatic carcinoma. To date, a miRNA expression profile can be 
used to identify the tissue of origin of carcinoma of unknown primary thanks to its tissue specificity8,9.
The present study aimed to find specific miRNAs that could serve as reliable and reproducible endogenous ref-
erence for FFPE lymph node tissue and to promote the further application of miRNA analysis. First, 10 miRNAs 
were selected as endogenous reference gene candidates from 71 small RNAs (Table 1). These consisted of 8 genes 
(miR-16, miR-24, miR-103a, miR-191, let-7a, U6 snRNA, SNORD44, and SNORD48), which are commonly used 
as reference in cancer studies3,7,10–12; 48 cancer-associated genes which have been used to identify cancer tissue 
origin8; and 15 genes of interest, which may be involved in cancer development. Then, the expression stability 
of the candidate genes was assessed using four statistical tools: BestKeeper13, geNorm14, NormFinder15, and the 
comparative ΔCt method16. Finally, stable gene sets were evaluated by comparing them with other normalization 
factors such as small nucleolar RNAs.
Results
Candidate genes and stability analysis. Fifty-one out of 71 genes, which were expressed in more than 
90% of the samples, were employed to calculate the internal reference value for the comparative ΔCt method 
with the global mean normalization strategy (ΔCtGlo) (Table 1). The top 10 endogenous reference gene candidates 
selected by the low variability of the ΔCtGlo values were miR-16, miR-21, miR-24, miR-34a, miR-92a, miR-103a, 
miR-148b, miR-152, miR-191, and let-7a. The distribution of raw Ct values of the 10 candidate genes in control 
and cancer groups is shown in Fig. 1. After subdivision on the basis of the location of primary tumor, a specific 
trend was not observed on raw Ct values.
The expression levels of these candidate genes were evaluated using BestKeeper analysis in all samples 
(Table 2). Among all candidate genes, miR-103a exhibited the best correlation between the BestKeeper Index and 
the candidate gene (r = 0.963, p ≤ 0.001). This BestKeeper Index was calculated using only seven genes excluding 
miR-16, miR-21, and miR-148b owing to their unacceptable variability (SD > 1.05). BestKeeper analysis deter-
mined that miR-103a was the most stable gene by combining a low standard deviation and a high correlation.
Using geNorm analysis, all 10 candidate genes had an M value below the recommended threshold of 1.5 
(Fig. 2a). This analysis indicated that miR-24 and miR-103a were the most stable genes among the 10 candidate 
genes (M = 0.699). However, a highly stable gene should have an M value below reference value of 0.5. geNorm 
Gene name SD (ΔCtGlo) Gene name SD (ΔCtGlo) Gene name SD (ΔCtGlo) No.
hsa-miR-191-5p† 0.67* hsa-let-7a-5p† 0.84* hsa-miR-193b-3p† 1.09
0
hsa-miR-24-3p† 0.68* hsa-miR-34a-5p† 0.84* hsa-miR-423-5p† 1.10
hsa-miR-152-3p† 0.72* hsa-miR-21-5p† 0.95* hsa-miR-29c-3p† 1.12
hsa-miR-148b-3p† 0.73* hsa-miR-16-5p† 0.98* hsa-let-7e-5p† 1.16
hsa-miR-103a-3p† 0.79* hsa-miR-29b-3p† 1.05 SNORD44† 1.19
hsa-miR-92a-3p† 0.82* hsa-miR-92b-3p† 1.05
hsa-let-7i-5p† 0.69 hsa-miR-193a-3p† 1.06 hsa-miR-145-5p† 1.81
1
hsa-miR-181b-5p† 0.70 hsa-miR-29a-3p† 1.07 hsa-miR-135a-5p† 1.83
hsa-miR-106b-5p† 0.76 hsa-miR-214-3p† 1.22 hsa-miR-31-5p† 1.84
hsa-miR-345-5p† 0.86 hsa-miR-130a-3p† 1.36 hsa-miR-192-5p† 1.91
hsa-miR-27b-3p† 0.94 hsa-miR-363-3p† 1.36 hsa-miR-194-5p† 1.92
hsa-miR-99a-5p† 0.98 hsa-miR-142-3p† 1.55 hsa-miR-210-3p† 1.95
hsa-miR-132-3p† 1.03 hsa-miR-181a-5p† 1.60
SNORD48† 1.06 hsa-miR-146a-5p† 1.65
hsa-miR-19b-3p† 0.97 U6 snRNA† 1.84 hsa-miR-155-5p† 1.24
≥2
hsa-miR-10b-5p† 1.50 hsa-miR-138-5p† 2.08 hsa-miR-148a-3p† 1.30
hsa-miR-196a-5p† 2.69 hsa-miR-141-3p† 3.52 hsa-miR-10a-5p† 1.35
hsa-miR-200c-3p† 3.39 hsa-miR-27a-3p† 1.09 hsa-miR-182-5p† 2.25
hsa-miR-153-3p 1.49 hsa-miR-592 2.22 hsa-miR-122-5p 2.60
≥6
hsa-miR-372-3p 1.57 hsa-miR-124-3p 2.30 hsa-miR-509-3p 2.68
hsa-miR-204-5p 1.62 hsa-miR-187-3p 2.33 hsa-miR-200a-3p 2.96
hsa-miR-572 1.84 hsa-miR-373-3p 2.36 hsa-miR-211-5p 3.02
hsa-miR-552-3p 1.89 hsa-miR-34b-5p 2.36 hsa-miR-375 3.76
hsa-miR-382-5p 1.98 hsa-miR-9-3p 2.38 hsa-miR-205-5p 5.12
hsa-miR-616-3p 2.00 hsa-miR-514a-3p 2.56
Table 1. The small RNAs used in this study. No.: number of undetected samples; SD: standard deviation. †These 
51 genes were used to calculate the global mean. *These 10 genes were selected as candidate reference genes.
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also identified the optimal number of reference genes in terms of the pairwise variation (V) between normaliza-
tion factors. As shown in Fig. 2a, the use of the five most stable genes was recommend for optimal performance 
(V value < 0.15) in our study.
NormFinder was used to calculate stability values derived from the intra- and inter-group variability. This 
analysis revealed that among the 10 candidate genes, miR-103a was the most stable gene (Stability value = 0.114) 
in sample groupings from metastatic cancer and non-cancerous tissues (Fig. 2b). The best combination recom-
mended by NormFinder was a set of miR-148b and miR-152 (Stability value = 0.087).
The comparative ΔCt method was used to identify the variability of all possible gene combinations within 
each sample. The stability of a gene was assessed by the mean of the standard deviations of the ΔCt values 
(ΔCtPair) over the pairs including the gene. As shown in Fig. 2c, miR-103a was identified as the most stable gene 
(Mean SD = 0.931) in all the samples, followed by miR-24 (Mean SD = 0.966) and miR-148b (Mean SD = 1.000).
The ranking assessment of expression stability by the four analyses is reported in Table 3. Combining the 
results of the four analyses, the ranking assessment of expression stability using the geometric mean suggested 
that miR-103a was the most stable gene, followed by miR-24 and let-7a.
Stability analysis of the combined genes. NormFinder selected miR-148b and miR-152 as the best 
combination. In addition, based on the stability rankings shown in Table 3, we chose the combination of two 
(miR-24/miR-103a) or three (miR-24/miR-103a/let-7a) genes. The stability analysis of these gene sets was 
Figure 1. The threshold cycle (Ct) value of qRT-PCR for candidate reference genes in each sample type. 
These samples were formalin-fixed, paraffin-embedded lymph node tissues from non-cancerous (Cont.) and 
metastatic cancer tissues (Breast, Colon, Lung, Ovary, Pancreas, Stomach, and Other represent the location of 
primary tumor). The dot plots represents the raw Ct values of reference gene candidates.
Gene miR-21 miR-16 miR-148b miR-92a miR-34a miR-191 miR-152 let-7a miR-24 miR-103a BKI (n = 10) BKI (n = 7)
N 57 57 57 57 57 57 57 57 57 57 57 57
GM [Ct] 22.733 23.492 29.789 26.157 27.999 27.741 29.281 24.124 25.017 26.058 26.138 26.573
AM [Ct] 22.786 23.543 29.825 26.182 28.026 27.762 29.311 24.170 25.059 26.102 26.165 26.598
Min [Ct] 18.592 19.075 26.276 22.905 25.543 24.954 27.126 21.330 22.417 23.362 23.983 24.757
Max [Ct] 27.486 29.219 34.338 28.479 31.928 30.182 33.021 30.964 30.615 32.121 30.087 30.484
SD [±Ct] 1.197 1.074 1.099 0.846 0.981 0.831 1.019 1.035 1.020 1.005 0.869 0.821
CV [%Ct] 5.255 4.562 3.685 3.231 3.500 2.994 3.478 4.280 4.070 3.852 3.320 3.086
r with BKI (n = 10) 0.830* 0.863* 0.914* 0.751* 0.785* 0.820* 0.842* 0.899* 0.929* 0.961* — —
r with BKI (n = 7) — — — 0.745* 0.780* 0.801* 0.854* 0.923* 0.942* 0.963* — —
Ranking 10 9 8 7 6 5 4 3 2 1 — —
Table 2. Descriptive statistics obtained by BestKeeper analysis. AM: arithmetic; BKI: BestKeeper Index; Ct: 
threshold cycle value; CV: coefficient of variation; GM: geometric; Max: maximum value; Min: minimum value; 
N: number of available samples; n: number of genes; r: Pearson correlation coefficient; SD: standard deviation; 
*p ≤ 0.001, P-value associated with the Pearson correlation coefficient. BKI was calculated for 10 genes and for 
seven genes, excluding the gene with the highest standard deviation.
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performed with the following normalization factors: global mean, miR-16, miR-191, miR-16/miR-345, miR-16/
let-7a, and U6/SNORD44/SNORD48. Because U6, SNORD44, and SNORD48 exhibited very low stability com-
pared with the five normalization factors, they were combined to avoid bias in the results. Briefly, U6, SNORD44, 
and SNORD48 were consistently ranked (8 th, 7 th, and 6 th, respectively) as the least stable genes by the four 
Figure 2. Stability analysis using geNorm, NormFinder, and the comparative ΔCt method. (a) The average 
gene expression stability (M value) and the pairwise variation value (V value) calculated by geNorm. (b) The 
inter- and intra-group variability and stability values estimated using NormFinder. In the variability graph, the 
error bars represent the average of the intra-group variability and the boxes indicate the confidence interval 
for the inter-group variability. (c) Mean standard deviation (Mean SD) was calculated by the comparative ΔCt 
method performing pairwise comparisons between genes (ΔCtPair).
Rank Gene
Overall 
Ranking
BestKeeper geNorm NormFinder Comparative ΔCtPair
r with BKI 
(Ranking)
M value 
(Ranking)
Stability value 
(Ranking) Mean SD (Ranking)
1 miR-103a 1.0 0.963 (1) 0.699 (1) 0.114 (1) 0.931 (1)
2 miR-24 1.9 0.942 (2) 0.699 (1) 0.120 (3) 0.966 (2)
3 let-7a 3.7 0.923 (3) 0.757 (3) 0.150 (5) 1.053 (4)
4 miR-191 4.3 0.801 (5) 0.975 (7) 0.119 (2) 1.066 (5)
5 miR-148b 4.9 −(8) 0.810 (4) 0.177 (6) 1.000 (3)
6 miR-152 5.6 0.854 (4) 0.882 (5) 0.188 (8) 1.071 (6)
7 miR-92a 6.7 0.745 (7) 1.012 (8) 0.149 (4) 1.170 (9)
8 miR-34a 7.2 0.780 (6) 1.042 (9) 0.185 (7) 1.128 (7)
9 miR-16 7.9 −(9) 0.933 (6) 0.226 (9) 1.147 (8)
10 miR-21 10.0 −(10) 1.073 (10) 0.233 (10) 1.197 (10)
Table 3. Calculation of the overall stability according to the four stability analyses used in this study. BKI: 
BestKeeper Index, calculated for seven genes; SD: standard deviation.
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stability analyses, e.g., BestKeeper indicated a high standard deviation for U6 (1.837) and SNORD44 (1.315) and 
a low correlation for SNORD48 (r = 0.538).
In the BestKeeper analysis (Table 4), miR-24/miR-103a/let-7a exhibited the highest correlation coefficients 
with BestKeeper Index (r = 0.981). U6/SNORD44/SNORD48 and miR-16 were excluded from the correlation 
analysis due to its high standard deviation of >1.05 (Table 4).
The M values of miR-24/miR-103a and miR-24/miR-103a/let-7a calculated by geNorm were lower than 0.5 
(Fig. 3a); therefore, these combinations were suggested as suitable endogenous references. NormFinder revealed 
that miR-148b/miR-152 had minimal inter- and intra-group variability, with a stability value of 0.094 (Fig. 3b). 
The results of the comparative ΔCtPair method demonstrated that miR-24/miR-103a/let-7a and miR-24/miR-103a 
had the lowest variability with standard deviations of 0.721 and 0.742, respectively (Fig. 3c).
The overall results of the stability analysis obtained using the statistical tools showed that miR-24/miR-103a/
let-7a ranked as the most stable gene combination, whereas U6/SNORD44/SNORD48 was the least stable com-
bination (Table 5).
Effects of normalization on relative quantification. We investigated the impact of normalization on 
the expression of miR-29c in a metastatic lymph node with colon cancer in comparison with that in a lymph node 
without cancer.
Figure 4 shows the expression of miR-29c normalized to each of the five normalization factors: miR-24, miR-
103a, miR-24/miR-103a, miR-24/miR-103a/let-7a and U6/SNORD44/SNORD48.
The expression of miR-29c normalized to miR-24/miR-103a/let-7a significantly decreased in a metastatic 
lymph node with colon cancer in comparison with that in a lymph node without cancer (p < 0.05). However, this 
difference was not detected when the expression of miR-29c was normalized to the other four factors.
Discussion
In this study, we presented the use of the mean Ct value of miR-24, miR-103a, and let-7a as a suitable normaliza-
tion factor for miRNA expression in FFPE lymph node tissue using qRT-PCR.
qRT-PCR is the gold standard method for miRNA quantitation because it is the most sensitive and reproduc-
ible method. However, the accuracy of results depends on the selected normalization factor. To obtain accurate 
data using qRT-PCR, many studies have identified stable reference genes in tissues other than lymph node, such 
as SNORD48 for atrial or organ tissue samples17,18, miR-16/let-7a for breast tissue samples10, and miR-16/miR-
345 for colorectal tissue samples19. Moreover, the use of a single reference gene, unless fully validated, is insuffi-
cient to obtain reliable miRNA expression20,21.
In fact, we had planned to identify the origin of the primary tumor using miRNA expression patterns in 
metastatic lymph node cells using qRT-PCR at first. However, we noticed that an endogenous reference gene for 
miRNA expression analysis had not been identified in FFPE lymph node with metastatic cancer. Prior to miRNA 
expression analysis, a suitable endogenous reference gene should be evaluated to avoid misinterpretation of data 
and identify true changes in miRNA expression levels7. Therefore, we validated that the combination of three 
miRNAs could be used as a suitable endogenous reference in a lymph node with metastatic cancer for qRT-PCR. 
This miRNA combination is not surprising because miR-24, miR-103a, and let-7a have been reported to exhibit 
a high expression stability in tumor tissue3,10–12. This suitable set of endogenous reference genes was determined 
based on the combination of four statistical approaches: BestKeeper, geNorm, NormFinder, and the comparative 
ΔCt method. These statistical analyses have been developed to identify optimal endogenous reference genes in a 
given set of samples. For the selection of candidate reference genes, we used the global mean normalization across 
51 genes (the comparative ΔCtGlo method). The global mean normalization can be used when a large number of 
miRNAs (typically more than 50) are analyzed in a sample. In addition, this normalization assumes that the mean 
Gene
U6/SNORD44/
SNORD48 miR-16 miR-191
miR-16/
miR-345
miR-148b/
miR-152
Global 
mean
miR-16/
let-7a
miR-24/
miR-103a
miR-24/miR-
103a/let-7a
BKI 
(n = 9)
BKI 
(n = 7)
N 57 57 57 57 57 57 57 57 57 57 57
GM [Ct] 28.048 23.492 27.741 26.638 29.540 28.658 23.813 25.540 25.070 26.426 26.647
AM [Ct] 28.094 23.543 27.762 26.670 29.568 28.678 23.856 25.581 25.110 26.455 26.674
Min [Ct] 24.824 19.075 24.954 22.945 27.445 26.577 20.613 23.162 22.905 24.400 24.700
Max [Ct] 32.169 29.219 30.182 30.726 33.680 31.885 29.628 31.368 30.848 30.718 30.889
SD [±Ct] 1.277 1.074 0.831 0.931 0.954 0.822 1.015 0.987 0.971 0.889 0.872
CV [%Ct] 4.545 4.562 2.994 3.490 3.226 2.866 4.255 3.857 3.867 3.360 3.269
r with 
BKI (n = 9) 0.757
* 0.910* 0.799* 0.899* 0.931* 0.951* 0.962* 0.968* 0.972* — —
r with 
BKI (n = 7) — — 0.808
* 0.897* 0.947* 0.955* 0.958* 0.975* 0.981* — —
Ranking 9 8 7 6 5 4 3 2 1 — —
Table 4. Descriptive statistics for combined genes obtained by BestKeeper analysis. AM: arithmetic; BKI: 
BestKeeper Index; Ct: threshold cycle value; CV: coefficient of variation; GM: geometric; Max: maximum value; 
Min: minimum value; N: number of available samples; n: number of factors; r: Pearson correlation coefficient; 
SD: standard deviation; *p ≤ 0.001, P-value associated with the Pearson correlation coefficient. BKI was 
calculated for 9 factors and for seven factors, excluding the gene with the highest standard deviation.
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expression of all miRNAs in a sample is constant. The Ct values of all 51 genes in a sample had normal distribu-
tion (Shapiro–Wilk test; p > 0.1 for all samples), which allowed the use of the global mean normalization method 
in our study. As mentioned in Methods, BestKeeper considers standard deviation and correlation of Ct values to 
assess stability13, whereas geNorm uses a pairwise comparison approach and assumes that the expression ratio of 
two ideal endogenous reference genes is identical in all samples, regardless of experimental conditions14. geNorm 
also calculates the optimal number of reference genes. It recommended the use of five reference genes for optimal 
normalization performance. However, we restricted our analysis to the combination of up to three genes, because 
we considered that the use of a larger number of reference genes may be impractical in further studies, such as 
the identification of tissue origin in cancers of unknown primary. NormFinder can account for heterogeneity 
among sample groups as it estimates intra- and inter-group variability15. In addition, NormFinder also allows the 
calculation of the stability values for a set of genes. It is important to note an imbalance of the number of samples 
between the control and the cancer groups. This imbalance may have an effect on NormFinder analysis, where 
Figure 3. Expression stability of endogenous reference gene candidates determined by geNorm, NormFinder, 
and the comparative ΔCtPair method. (a) The M values and V values calculated by geNorm. (b) The inter- (box) 
and intra- (error bars) group variability and stability values determined using NormFinder. (c) Mean standard 
deviation (Mean SD) was calculated by the comparative ΔCtPair method.
Rank Gene
Overall 
Ranking
BestKeeper geNorm NormFinder
Comparative 
ΔCtPair
r with BKI 
(Ranking)
M value 
(Ranking)
Stability value 
(Ranking)
Mean SD 
(Ranking)
1 miR-24/miR-103a/let-7a 1.3 0.981 (1) 0.235 (1) 0.095 (3) 0.721 (1)
2 miR-24/miR-103a 2.0 0.975 (2) 0.235 (1) 0.096 (4) 0.742 (2)
3 miR-148b/miR-152 2.9 0.947 (5) 0.448 (3) 0.094 (1) 0.785 (5)
4 Global mean 4.1 0.955 (4) 0.515 (4) 0.108 (6) 0.750 (3)
5 miR-16/let-7a 4.2 0.958 (3) 0.572 (5) 0.104 (5) 0.771 (4)
6 miR-16/miR-345 4.6 0.897 (6) 0.639 (6) 0.094 (2) 0.882 (6)
7 miR-16 7.5 −(8) 0.694 (7) 0.147 (8) 0.958 (7)
8 miR-191 7.5 0.808 (7) 0.763 (8) 0.124 (7) 1.016 (8)
9 U6/SNORD44/SNORD48 9.0 −(9) 0.879 (9) 0.179 (9) 1.282 (9)
Table 5. Stability ranking of the endogenous reference gene candidates. BKI: BestKeeper Index; SD: standard 
deviation.
www.nature.com/scientificreports/
7SCIEnTIFIC REpORTs |  (2018) 8:5918  | DOI:10.1038/s41598-018-24338-7
balanced populations are generally requested. The comparative ΔCtPair method compares relative expression of 
‘pairs of genes’ within each sample for all candidate gene combinations16.
The stability of selected gene sets were evaluated using the other normalization factors (i.e., global mean, 
miR-16, miR-191, miR-16/miR-345, miR-16/let-7a, U6/SNORD44/SNORD48). These factors are commonly 
used as reference for miRNA quantitation in cancer tissue7,10,12,19. Based on the initial analysis, we combined U6, 
SNORD44, and SNORD48. These three genes are well-known reference genes in miRNA analysis, however, their 
use has been reported to involve high variability in some experimental conditions12.
Consequently, these multiple analyses revealed that the combination of miR-24/miR-103a/let-7a was the 
most stable endogenous normalization factor in our experimental conditions. miRNA expression stability must 
be carefully assessed in each specific experimental setting, because it is also possible that these miRNAs might 
be also associated with lymph node metastasis. In fact, the aberrant expression of miR-24 (higher expression) 
and let-7a (lower expression) in breast cancer is shown to play a key role in tumor invasion and metastasis22,23. 
Therefore, a combination of three miRNAs has an important meaning to avoid erroneous results.
We also quantified the expression levels of miR-29c in a metastatic lymph node with colon cancer to evalu-
ate the normalization efficiency by four different endogenous factors. A significant downregulation of miR-29c 
expression was observed in the metastatic lymph node when data were normalized to the combination of miR-
24/miR-103a/let-7a. The downregulation of miR-29c expression has been reported in various cancers including 
colon cancer24,25. Although the function of miR-29c expression in colon cancer has not been clarified, miR-29c 
exhibits a tumor suppressor function in several types of cancer by targeting TNFAIP3 and cyclin E, thereby inhib-
iting tumorigenesis and metastasis25–27. Thus, the use of the other normalization factors, which did not reveal the 
significant downregulation of miR-29c, should be discouraged for FFPE lymph node studies because it may lead 
to incorrect results.
To our knowledge, this is the first study to determine reference genes in FFPE lymph node tissues from 
patients with different kinds of cancer. Our result suggests the importance of assessing the gene stability for each 
experimental condition.
We acknowledge some limitations of the present study as follows: the relatively small sample size; the 
qRT-PCR assay based on SYBR Green, which is not so specific as the TaqMan method; the absence of replicates in 
the determination of Ct values; and the fact that the analysis of combined genes involved repeated elements (e.g., 
miR-24/miR-103a and miR-24/miR-103a/let-7a) with potential correlations among sets, which may have affected 
the analyses. Although this study assessed the stability of 71 genes including the most commonly used reference 
genes, more suitable reference gene combinations may be identified in the future. Our results should be applied to 
FFPE lymph node tissue in humans. Therefore, it does not eliminate the use of common reference genes in other 
experimental conditions.
Figure 4. Effect of normalization on the expression of miR-29c in formalin-fixed, paraffin-embedded lymph 
node tissue. Relative expression of a metastatic lymph node (Colon: n = 5) was compared with a lymph node 
without cancer (Cont.: n = 16). The expression levels (2−ΔCt) of miR-29c are shown as box plots (log2 scale 
on the y-axis). The median is represented as a horizontal line within each box and its lower and upper edges 
represent the 25–75 percentile region. The whiskers represent the 10–90 percentile region, and the dots 
represent the outliers. Statistically significant differences were determined using the Mann–Whitney U test 
(two-tailed test).
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Conclusion
We identified a suitable endogenous reference that can be used to study miRNA expression in FFPE lymph node 
tissue from patients with metastatic cancer. This result will provide valuable information for future miRNA 
expression studies in FFPE lymph node tissue samples with metastatic cancer.
Methods
Tissue samples and ethical statement. FFPE lymph node tissue samples were obtained from 41 meta-
static cancer and 16 non-cancerous tissues at Ibaraki Prefectural Central Hospital, Japan. The characteristics of 
the samples are presented in Table 6.
This study was approved by the institutional review board of Ibaraki Prefectural Central Hospital, Japan. 
Informed consent was obtained for the use of archived clinical specimens, and all experimental methods were 
performed in accordance with the relevant guidelines and regulations.
Total RNA isolation from FFPE lymph node tissue. Total RNA was extracted from four FFPE sections 
of 10-µm thickness using miRCURY™ RNA Isolation Kit (Exiqon, Vedbæk, Denmark) in accordance with the 
manufacturer’s instructions. RNA concentrations were measured using a NanoDrop ND-2000 spectrophotome-
ter (NanoDrop Technologies, Wilmington, DE, USA). Only RNA samples with a 260/280 ratio of ≥1.8 were used.
Quantitative real-time PCR. Total RNA (10 ng) isolated from FFPE tissue samples were reverse tran-
scribed using miRCURY LNA Universal RT cDNA synthesis kit II with RNA spike-in (Exiqon) in a 10 µL reac-
tion volume for 60 min at 42 °C and 5 min at 95 °C, according to the manufacturer’s instructions. The reverse 
transcription product (cDNA) was diluted 100-fold and quantified by qRT-PCR using an ExiLENT SYBR Green 
master mix (Exiqon). qRT-PCR was performed in custom-made 96-well Pick & Mix microRNA PCR panel plates 
(Exiqon) and a 7500 Fast Dx Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). This PCR panel 
plates consisted of the 71 candidate genes (a single well for each gene) and the following quality controls: UniSp3 
(triplicate), UniSp6 (single), and cel-miR-39 (single). The PCR protocol was applied as follows: incubation for 
10 min at 95 °C, followed by 40 cycles of 10 s at 95 °C and 1 min at 60 °C, with a final melting curve analysis. The Ct 
values for qRT-PCR were determined using the SDS v1.4 software (Applied Biosystems) and the single-threshold 
method. Ct values that displayed unusual amplification curves (e.g., low amplification efficiency) were excluded 
from further analysis.
Selection of candidate genes and stability analysis. Ten candidate genes were selected based on the 
comparative ΔCt method with the global mean as the endogenous control. The global mean value was calculated 
as the mean Ct value of the genes detected in a sample. Only highly expressed genes (expressed in more than 90% 
of the samples) were selected for the global mean method. For these genes, the normal distribution of Ct values 
was tested by Shapiro–Wilk test. Global mean normalization has been demonstrated to be one of the highly accu-
rate approaches for miRNA expression analysis20.
Sample Group
Location of
primary tumor
N
(F; M)
Mean age
(Range) Subtype (N)
Metastatic LN
Breast
5 58
Invasive carcinoma (5)
(5; 0) (41–81)
Colon
5 68.6
Adenocarcinoma (5)
(1; 4) (56–75)
Lung
5 66.4 Small cell carcinoma (1), Squamous cell carcinoma (1), 
Adenocarcinoma (3)(4; 1) (57–76)
Ovary
3 69.3
Squamous cell carcinoma (1), Adenocarcinoma (2)
(3; 0) (65–76)
Pancreas
8 67.1
Carcinoma (1), Adenocarcinoma (7)
(2; 6) (57–77)
Stomach
5 69.8
Adenocarcinoma (5)
(2; 3) (62–79)
Other
10 75.4 Carcinoma (not specified) (3), Small cell carcinoma (1), Squamous cell 
carcinoma (1), Adenocarcinoma (3), Melanoma (2)(5; 5) (58–90)
Total
41 69 Carcinoma (9), Small cell carcinoma (2), Squamous cell carcinoma (3), 
Adenocarcinoma (25), Melanoma (2)(22; 19) (36–90)
Non-cancerous LN —
16 76
Reactive LN without any tumor cells (16)
(8; 8) (51–83)
Table 6. Characteristics of the samples. F: female; LN: lymph node; M: male; N: number of samples; “Other” 
includes endometrial, thyroid, esophagus, and prostate cancers; cholangiocellular carcinoma; and malignant 
melanoma. The non-cancerous samples were mainly obtained from lymph node dissection and without any 
findings of cancer metastasis at histological analysis. They are from patients with lung cancer (5), bile duct 
cancer (3), endometrial cancer (2), colon cancer (1), hypopharynx cancer (1), malignant melanoma (1), parotid 
cancer (1), stomach cancer (1), and reactive mesenteric lymph node of ulcer of the small intestine (1).
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The ΔCtGlo value was calculated by the following equation: ΔCtGlo = Target gene Ct − Global mean Ct. In this 
analysis, gene stability was assessed by the standard deviation of the ΔCtGlo values. The standard deviation was 
given for the variability in ΔCtGlo values in all samples.
BestKeeper13 analysis determines the most stably expressed gene based on the Pearson correlation coefficient 
(r) of the BestKeeper Index, which is the geometric mean of Ct values of candidate genes. Based on the raw Ct 
values of each sample, standard deviation was calculated, and high standard deviations (>1) were considered 
inadequate.
geNorm14 analysis evaluates the stability of candidate reference genes based on the average pairwise variation 
of a gene compared with that of all other genes. Next, it identifies the optimal number of reference genes required 
by analyzing the pairwise variation (Vn/n + 1) among candidate genes. The gene stability value (M value) and the 
pairwise variation value (V value) were calculated with the geNorm software using 2−ΔCtMin values. The ΔCtMin 
value was calculated by the following equation: ΔCtMin = Target gene Ct − Min Ct, where Min Ct is the lowest Ct 
value of a candidate gene. The lowest M value indicates the most stable expression, and values under 0.5 indicate 
an acceptably stable expression. The number of reference genes was considered as optimal when the V value was 
below 0.15.
NormFinder15 analysis is based on an ANOVA model that considers intra- and inter-group variability to eval-
uate the expression stability of a candidate gene. In this study, expression variations between the metastatic cancer 
and non-cancerous tissue were focused on. Exponentially transformed data (2−Ct value) were used as input data in 
the NormFinder software. The lowest stability value indicates the most stably expressed gene.
In the comparative ΔCt method16, we calculated the ΔCtPair values for each pair of reference gene candidates, 
and assessed the stability of each gene using the mean of the standard deviations obtained from all the pairwise 
comparisons including the gene.
The overall stability ranking of candidate genes was determined using the geometric mean of the rankings 
generated from all four analyses.
Assessment of stability for combined genes. In addition to the best reference gene, NormFinder iden-
tified also the best combination of two genes. In addition, based on the overall stability ranking, combinations of 
two or three genes were determined as endogenous reference candidates. To evaluate the stability of combined 
genes, stability analyses were performed in combination with other normalization factors (i.e., global mean, miR-
16, miR-191, miR-16/miR-345, miR-16/let-7a, U6 snRNA, SNORD44, and SNORD48).
Effect of normalization. To evaluate the effectiveness of the endogenous reference chosen in this study, the 
expression levels of miR-29c was measured using various reference genes. Relative expression levels were reported 
as 2−ΔCt. The Mann–Whitney U test was used to determine statistically significant differences in expression levels 
between the metastatic cancer and non-cancerous tissue. Statistical analysis was performed with GraphPad Prism 
6.03 (GraphPad Software, San Diego, CA, USA). P-values of <0.05 were considered statistically significant.
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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